ATE245985T1 - Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen - Google Patents
Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzenInfo
- Publication number
- ATE245985T1 ATE245985T1 AT98901665T AT98901665T ATE245985T1 AT E245985 T1 ATE245985 T1 AT E245985T1 AT 98901665 T AT98901665 T AT 98901665T AT 98901665 T AT98901665 T AT 98901665T AT E245985 T1 ATE245985 T1 AT E245985T1
- Authority
- AT
- Austria
- Prior art keywords
- nitrogen oxide
- oxide synthase
- treat pain
- opioid tolerance
- inhibiting inducible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Materials For Medical Uses (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Processing Of Meat And Fish (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78181497A | 1997-01-09 | 1997-01-09 | |
| PCT/US1998/000006 WO1998030220A1 (en) | 1997-01-09 | 1998-01-06 | Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE245985T1 true ATE245985T1 (de) | 2003-08-15 |
Family
ID=25124020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98901665T ATE245985T1 (de) | 1997-01-09 | 1998-01-06 | Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0966286B1 (de) |
| JP (1) | JP2001508444A (de) |
| AT (1) | ATE245985T1 (de) |
| AU (1) | AU5813098A (de) |
| CA (1) | CA2272941A1 (de) |
| DE (1) | DE69816790T2 (de) |
| DK (1) | DK0966286T3 (de) |
| ES (1) | ES2205441T3 (de) |
| PT (1) | PT966286E (de) |
| WO (1) | WO1998030220A1 (de) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225440A (en) * | 1991-09-13 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuation of the opioid withdrawal syndrome by inhibitors of nitric oxide synthase |
| US5256669A (en) * | 1992-08-07 | 1993-10-26 | Aminotek Sciences, Inc. | Methods and compositions for treating acute or chronic pain and drug addiction |
| US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
| CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
| JPH09504524A (ja) * | 1993-10-21 | 1997-05-06 | ジー.ディー.サール アンド カンパニー | 酸化窒素シンターゼ阻害剤として有用なアミジノ誘導体 |
| US5726156A (en) * | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| ATE195933T1 (de) * | 1994-03-10 | 2000-09-15 | Searle & Co | L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren |
| DE4442116A1 (de) * | 1994-11-25 | 1996-05-30 | Cassella Ag | 2-Amino-1,3-thiazine als Hemmstoffe der Stickstoffmonoxid-Synthase |
| WO1996018616A1 (en) * | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
| GB9425701D0 (en) * | 1994-12-20 | 1995-02-22 | Wellcome Found | Enzyme inhibitors |
| AU712995B2 (en) * | 1995-05-10 | 1999-11-18 | G.D. Searle & Co. | Nitric oxide synthase inhibitors derived from cyclic amidines |
-
1998
- 1998-01-06 AT AT98901665T patent/ATE245985T1/de not_active IP Right Cessation
- 1998-01-06 AU AU58130/98A patent/AU5813098A/en not_active Abandoned
- 1998-01-06 ES ES98901665T patent/ES2205441T3/es not_active Expired - Lifetime
- 1998-01-06 DE DE69816790T patent/DE69816790T2/de not_active Expired - Fee Related
- 1998-01-06 DK DK98901665T patent/DK0966286T3/da active
- 1998-01-06 PT PT98901665T patent/PT966286E/pt unknown
- 1998-01-06 WO PCT/US1998/000006 patent/WO1998030220A1/en not_active Ceased
- 1998-01-06 CA CA002272941A patent/CA2272941A1/en not_active Abandoned
- 1998-01-06 JP JP53096198A patent/JP2001508444A/ja not_active Abandoned
- 1998-01-06 EP EP98901665A patent/EP0966286B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001508444A (ja) | 2001-06-26 |
| DE69816790T2 (de) | 2004-04-22 |
| EP0966286B1 (de) | 2003-07-30 |
| DE69816790D1 (de) | 2003-09-04 |
| WO1998030220A1 (en) | 1998-07-16 |
| DK0966286T3 (da) | 2003-11-17 |
| ES2205441T3 (es) | 2004-05-01 |
| EP0966286A1 (de) | 1999-12-29 |
| PT966286E (pt) | 2003-12-31 |
| AU5813098A (en) | 1998-08-03 |
| CA2272941A1 (en) | 1998-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973900D0 (no) | Nitrogenoksyd syntase inhibitorer | |
| DE69941949D1 (de) | topische ZUSAMMENSETZUNGEN enthaltend einen alpha 1-adrenergic blocker ZUR BEHANDLUNG VON SCHMERZHAFTEN ZUSTÄNDEN DER ANALREGION | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| UA49006C2 (uk) | Похідні 6-фенілпіридил-2-аміну, фармацевтична композиція, спосіб інгібування синтази оксиду нітрогену у ссавців та спосіб лікування | |
| ATE271128T1 (de) | Inhibitoren der il-6 aktivitaet | |
| HUP0004532A2 (en) | Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor | |
| EA199900448A1 (ru) | Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos | |
| SE9703693D0 (sv) | Novel combination | |
| TR200200204T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi. | |
| DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
| IL158559A0 (en) | Acne treatment | |
| BR9812371A (pt) | Tratamento de distúrbio de conduta | |
| DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
| NO994640D0 (no) | Hostestillende midler | |
| EA200000165A1 (ru) | Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos | |
| NO994330D0 (no) | Metode for behandling av en tumor | |
| DE60101559D1 (de) | Benutzung von comt-inhibitoren als analgetika | |
| ATE541565T1 (de) | Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus | |
| HUP0100066A2 (hu) | Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére | |
| HRP20050572A2 (en) | Pde4 and pde3/4 inhibitors for use in the treatment of cachexia | |
| ATE245985T1 (de) | Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen | |
| ZA9711468B (en) | New use of comt inhibitors | |
| ATE338566T1 (de) | Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten | |
| AP2001002067A0 (en) | New pharmaceutical uses for nos inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0966286 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |